Don't worry, you will be lucky if you see $5.66. The downtrend will speed up next week and a fresh 52-week low will be marked. Do not repeat you mistake and exit before you lose all your money.
This is total irresponsibility of CEO and CFO. They have zero vision and zero market experience.
SPPI continues to go lower and lower and the recent hype by Armistice did not affect the company. I mean, there is no improvement in revenue or any change in management. Armistice was the last push for some shareholders to exit with lower losses before more detrition of situation. SPPI estimates are down significantly and they are getting much worse. Previous lows or even new lows are in view.
That is says it all. Revenue from all drugs are shrinking. Reducing marketing and sales force too.
pipeline is not the total answer. It takes years before SPPI get to this point if all stars are lined up.
Why does not SPPI provide patent expiration for its drugs like most of biopharmas?
Why should investors hear news like Sandoz from media first before SPPI say anything?
If SPPI put the expiration for its drugs then investors could exit before losing their investment.
After all, why are you defending a company that does many wrong things? It is time for you to exit and save yourself.
This is exactly the point. They coordinate together. Yes, they, means people outside and inside of the company. Unfortunately some new people fall for their trick and buy some shares and lose money eventually.
An activist needs to have over 10% of shares before opening his mouth.
Obviously, Boyed wanted a quick money and retails gave him the money in past few days.
Boyed is selling now. Who knows, he may be Raj's friend too.
You are right about PPS which will be down.
The report doesn't matter if it better than expectation since investors look forward. Bad report may hint early Fusilev loss. However, Investors want to know about Fusilerv future. Will it be a dead drug for SPPI? Analysts will ask tough questions and the management cannot hide the truth. They better come up with straight answers.
And then saying he knew this would coming. Then why he did not tell investors before?
Stocks.toshort is right. SPPI will go lower regardless of any pump by some people here.
I have been watching andd even traded the stock for past few months. The PPS is under control of some hidden hands. It marked a few 52-weeks low with no news and it held itself with the worst earnings report. When retails are expecting to go lower, it won't but when everything seems to be ok, it drops like a rock. But, overall trend is downward. I am sure it will see low $5 in next few weeks.
Energy stocks will recover and I am watching chk and emes.
Recently, I read an article from Seeking Alpha that indicated that when DEPO dropped 15% on mid May after Q1 report, DEPO CEO and a director were among investors who bought DEPO shares.
How many times SPPI big guys have done this? It is not expect for a similar action as DEPO but at least they should not sell before a big drop in the stock price. That is the difference between SPPI and other companies.
3 times reps are marketing Nucynta with 44% higher price.
Do a math, DEPO profit is on a sharp rise.
Next acquisition is planned and DEPO is not stopping at this point.
If HZNP can do it, DEPO can do much better.